Browse by category

FDA approves Veru’s trial with Enobosarm to treat muscle loss associated with weight loss drugs

The FDA has cleared Veru’s Investigational New Drug (IND) application for its Phase 2b clinical study to evaluate enobosarm, an oral...

Preoperative antihypertensive drugs and visceral fat area can predict hypertension remission and recurrence post-LSG

Dec 19

Muscle-preserving weight loss drug ASC47 plus semaglutide is superior to semaglutide monotherapy for weight loss

Dec 19

Racial and ethnic groups face barriers to obtaining OMMs

Dec 19

Weekly Digest